Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Diabetic Gastroparesis Treatment Market Outlook

The global diabetic gastroparesis treatment market size was valued at USD 3.64 billion in 2023, driven by the improvements in the arena of healthcare and gastric treatments. The market is anticipated to grow at a CAGR of 4.1% during the forecast period 2024-2032 to reach a value of USD 5.87 billion by 2032. 

Diabetic Gastroparesis Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Advancements in Healthcare and Gastric Treatments to Aid the Market Growth of Diabetic Gastroparesis Treatment

The market for diabetic gastroparesis treatment is being driven by the improvements in the arena of healthcare and gastric treatments. The market is further aided by the growing cases of diabetes across the globe. Further, the existence of a seamless healthcare industry lays emphasis on the swift treatment and diagnosis, which is also propelling the market forward. Diabetic gastroparesis severely affects the quality of life. Therefore, medical practitioners are showing tremendous concern for the patient while treating such disorders, consequently enhancing the market growth. In addition, the availability of dieticians and professionals who can advise the patient regarding proper food consumption and food habits is also contributing to the market growth of diabetic gastroparesis treatment. All these factors are expected to support the market growth over the forecast period as well.

Diabetic Gastroparesis Treatment Market By Distributional Channel

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Diabetic Gastroparesis Treatment: Market Segmentation

Diabetic gastroparesis treatment is the treatment for delayed gastric emptying related to diabetes. The condition is observed in patients suffering from type-1 and type-2 diabetes and is found to be frequent in female patients that are suffering from type-2 diabetes.

On the basis of type, the market is divided into:

  • Surgical Treatment Products
  • Drugs

Based on disease indication, the industry can be segmented into:

  • Compensated Gastroparesis
  • Gastric Failure
  • Others

By distribution channel, the industry is categorised into:

  • Hospital Pharmacies 
  • Drug Stores
  • Private Clinics
  • Retail Pharmacies
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Diabetic Gastroparesis Treatment Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Cases of Diabetes to Aid the Market Growth of Diabetic Gastroparesis Treatment

The diabetic gastroparesis treatment industry is being driven by the need to meet the evolving demands within the diabetic treatment and diagnostics sector. The market is further aided by the rising cases of type-I and type-II diabetes. Furthermore, the rising demand for minimally invasive treatments and surgeries for the diabetic gastroparesis is also providing an impetus to the market growth as it has created significant growth opportunities within the industry. Moreover, the development of new drug lines within the industry is expected to boost the market growth of diabetic gastroparesis treatment over the forecast period.

Key Industry Players in the Global Diabetic Gastroparesis Treatment Market

The report gives a detailed analysis of the following key players in the global diabetic gastroparesis treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Evoke Pharma, Inc.
  • Allergan plc
  • Salix Pharmaceuticals
  • Theravance Biopharma, Inc.
  • Medtronic, plc 
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Disease Indication
  • End User
  • Route of Administration
  • Region
Breakup by Type
  • Surgical Treatment Products
  • Drugs
Breakup by Disease Indication
  • Compensated Gastroparesis
  • Gastric Failure
  • Others
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Homecare
Breakup by Route of Administration
  • Oral
  • Injectables
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Evoke Pharma Inc.
  • Allergen Pnc.
  • Salix Pharmaceuticals
  • Theravance Biopharma Inc.
  • Medtronics pLC
  • Abbot
  • Rhythm Pharmaceuticals
  • Allergen plc.
  • Astrazeneca plc.
  • Cadila Pharmaceuticals
  • Neurogastrx Inc
  • Bausch Health
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The global diabetic gastroparesis treatment market reached a value of USD 3.64 billion in 2023.

The market is projected to grow at a CAGR of 4.1% during the forecast period of 2024-2032 to reach a value of USD 5.87 billion by 2032.

The major drivers of the industry, such as rising disposable incomes, increasing population, growing improvements in the arena of healthcare and gastric treatments, rising prevalence of diabetes, increasing availability of dieticians and professionals, and growing demand for minimally invasive treatments and surgeries for the diabetic gastroparesis, are expected to aid the market growth.

The key trends guiding the growth of the market include the rising development of new drugs and advancements in the healthcare industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific. 

The leading types of diabetic gastroparesis treatment in the industry are surgical treatment products and drugs.

The major disease indications in the market are compensated gastroparesis and gastric failure, among others.

The significant distribution channels in the industry are hospital pharmacies, drug stores, private clinics, and retail pharmacies, among others.

The major players in the industry are Evoke Pharma, Inc., Allergan plc, Salix Pharmaceuticals, Theravance Biopharma, Inc., and Medtronic, plc, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124